Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Research
New York Times: Clinical Trial Subjects and Hard Choices
Doctors make extremely difficult decisions every day. It is one of the hardest parts of their job. They must choose whether…
Cleveland Clinic’s Guy Chisolm: Physician Industry Collaboration and…
During a recent interview, Dr. Guy Chisolm, Director of the Innovation Management and Conflict of Interest program at the…
Orphan Diseases Desperate for a Cure
There are more than 5,000 diseases designated as “orphan” because there are so few “sufferers that most pharmaceutical companies…
Pharmaceutical Development Challenges Includes Deficit in Human Capital
Pharmaceutical development and discovery has faced significant challenges over the past several years. While the rate at which new…
Price Regulation and the Consequences to Innovation
A recent white paper published by the European School of Management and Technology (ESMT), carried out “An Economic Assessment of…
IFPMA Joint Industry Position on the Publication of Clinical Trial Results…
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is the global non-profit NGO…
America’s 60 Experts In Multiple Myeloma Support Continued Collaboration…
America’s top experts in multiple myeloma published a manifesto on value of their working relationship with industry in the Mayo…
AHA and ACCME Reach Agreement on Industry Scientists Presenting at…
The AHA and ACCME have reached an agreement on industry scientists presenting at their annual meeting. The ban on industry…
Cancers Two Steps Forward
During the health care debate, many believed that America was far behind other countries in the quality and effectiveness of our…
Current Regulatory Environment: Clinical Trials Difficult To Manage
The Association of Clinical Research Organizations (ACRO) provides an active voice for the global CRO industry by representing…